Waldencast Announces Strong Progress on Business Priorities for H1 2025 and Initiatives to Drive Transformation

Obagi Medical delivers H1 2025 double-digit growth in its Core Strategic Channels. Novaestiq Acquisition Doubles the Brand’s Addressable Market in the U.S.

Read more at globenewswire.com